Search

Background Among the various methods available, the administration of prostaglandins is the most effective for inducing labour in women with an unfavourable cervix. Recent studies have compared treatment with various titrated doses of oral misoprostol with vaginal misoprostol or dinoprostone, indicating that the use of an escalating dose of an oral misoprostol solution is associated with a lower rate of caesarean sections and a better safety profile. The objective of this study is to assess which of these three therapeutic options (oral or vaginal misoprostol or vaginal dinoprostone) achieves the highest rate of vaginal delivery within the first 24 h of drug administration. Methods An open-label randomised controlled trial will be conducted in Araba University Hospital (Spain). Women at ≥41 weeks of pregnancy requiring elective induction of labour who meet the selection criteria will be randomly allocated to one of three groups: 1) vaginal dinoprostone (delivered via a controlled-release vaginal insert containing 10 mg of dinoprostone, for up to 24 h); 2) vaginal misoprostol (25 μg of vaginal misoprostol every 4 h up to a maximum of 24 h); and 3) oral misoprostol (titrated doses of 20 to 60 μg of misoprostol following a 3 h on + 1 h off regimen up to a maximum of 24 h). Both intention-to-treat analysis and per-protocol analysis will be performed. Discussion The proposed study seeks to gather evidence on which of these three therapeutic options achieves the highest rate of vaginal delivery with the best safety profile, to enable obstetricians to use the most effective and safe option for their patients. Trial registration NCT02902653 Available at: https://clinicaltrials.gov/show/NCT02902653 (7th September 2016). Electronic supplementary material The online version of this article (10.1186/s12884-018-2132-3) contains supplementary material, which is available to authorized users.

Incubators are heterogeneous but there is a lack of understanding of the variety of innovation involved. We use four archetypes of incubator discussed in the literature (basic research, university, economic development and private incubator) and analyze their generation of different types of innovation (product, technological process and organizational innovation) during a 4 years period (2005–2008). In a sample of 80 incubators, we find that incubatees in some types of incubators are more prone to generate product and technological process innovations than those hosted in other types.

The effects of sodium dodecyl sulfate (SDS) on the structure of histones H1 as model proteins have been studied by a combination of difference spectroscopy, circular dichroism (CD), and spectrofluorometry. The detergent increases the α-helix content at the expense of random-coiled regions. As measured by CD, this transition involves 44–50 residues in calf H1. Assuming that positive charges in the amino acid side chains are no longer an impediment to the formation of α-helix in the presence of SDS, the use of the method of prediction of secondary structure elaborated by Chou and Fasman gives an estimate of six regions with high helix-forming potential. One of these peptides lies in the NH2-terminal region (residues 22–29), whereas the five remaining peptides are in the COOH-terminal region of the histone (residues 109–114, 120–125, 142–151, 185–189, and 202–211). These six peptides amount to 45 residues, in good agreement with experimental results. We have also studied the action of the detergent on the environment of tyrosyl residues of calf H1 (one tyrosine) andCeratitis capitata H1 (two tyrosines). Difference spectroscopy and CD show that the environment of tyrosine-72 of calf H1 in the histone-SDS complex differs from both the native state and the acid-denatured state. The two tyrosyl residues ofCeratitis H1, whose environments in the native protein are markedly different, are included in similar environments in the histone-SDS complex.